Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

被引：0

作者：

Young June Choe

Emmanuel Vidor

Christine Manson

机构：

[1] Medical Affairs,

[2] Sanofi,undefined

[3] Global Medical Affairs,undefined

[4] Sanofi,undefined

[5] Global Pharmacovigilance,undefined

[6] Sanofi,undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

Diphtheria; DTaP-IPV; Pertussis; Polio; Post-marketing surveillance; Safety; Tetanus; TETRAXIM™; Vaccines;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

页码：1479 / 1492

页数：13

共 46 条

[41] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
Hee Soo Kim
Yongho Oh
Joanna Korejwo
Valérie Bosch Castells
Kuhyun Yang
Infectious Diseases and Therapy, 2020, 9 : 589 - 598
[42] Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean Infants
Tregnaghi, Miguel W.
Zambrano, Betzana
Santos-Lima, Eduardo
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (06) : E88 - E96
[43] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(R)) in South Korea, 2015-2019
Kim, Hee Soo
Oh, Yongho
Korejwo, Joanna
Castells, Valerie Bosch
Yang, Kuhyun
INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 589 - 598
[44] Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine A randomized, controlled trial in children primed according to a 2+1 schedule in infancy
Ferrera, Giuseppe
Cuccia, Mario
Mereu, Gabriele
Icardi, Giancarlo
Bona, Gianni
Esposito, Susanna
Marchetti, Federico
Messier, Marc
Kuriyakose, Sherine
Hardt, Karin
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (03)
[45] An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
Gaël Dos Santos
Raghavendra Devadiga
Chun Soo Kim
Joon Bang
Drug Safety, 2024, 47 (4) : 365 - 375
[46] An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
Dos Santos, Gael
Devadiga, Raghavendra
Kim, Chun Soo
Bang, Joon
DRUG SAFETY, 2024, 47 (04) : 365 - 375

← 1 2 3 4 5 →